|
|
|
| Atorvastatin Combined with Trimetazidine on the Expression Level of Caspase-1 and IL-18 of patients with CHD |
| YUAN Xiaorong, XU Ping, YANG Bo |
| Luzhou Hospital of Traditional Chinese Medicine, Sichuan Luzhou 646000, China |
|
|
|
|
Abstract Objective: To investigate the effects of atorvastatin combined with trimetazidine for the treatment of patients after the in vivo Caspase-1 and IL-18 expression changes. Methods: 100 cases of patients with coronary heart disease (CHD) admitted in our hospital from July 2013 to July 2015 were randomly divided into observation group and control group; the control group was treated with trimetazidine treatment, observation group were treated with atorvastatin combined with trimetazidine treatment sibutramine; patients after the treatment, assessment, intervention at the end of the observation before and after treatment in patients with blood rheology blood lipid levels, learning condition, and the levels of Caspase-1 and IL-18 in serum. Results: The effective rate of the observation group was significantly higher than the control group, and the difference has statistical significance (P<0.05); After treatment, The TC, TG, HDL-C and LDL-C levels of Patients were significantly decreased (P<0.05), and the observation group was significantly lower than that of control group (P<0.05); red blood cell hematocrit and plasma viscosity the whole blood viscosity and low shear rate and high shear rate of whole blood viscosity patients was significantly reduced (P<0.05), and the observation group was significantly lower than that of control group (P<0.05);The Caspase-1 levels of patients two groups were significantly decreased (P<0.05), and the observation group was significantly lower than that of control group (P<0.05); IL-18 in two groups significantly decreased (P<0.05), and the observation group was significantly lower than that of control group (P<0.05). Conclusion: The trimetazidine and atorvastatin on the prognosis of patients with CHD can improve the blood lipid and blood rheology in patients with learning condition, reduce the levels of Caspase-1 and lower the level of IL-18, it has high value in clinical application.
|
|
|
|
|
|
[1] Opolski M P,Pregowski J,Kruk M,et al.The prevalence and characteristics of intra-atrial right coronary artery anomaly in 9,284 patients referred for coronary computed tomography angiography[J].European Journal of Radiology,2014,83(7):1129~1134.
[2] 田磊.阿托伐他汀与曲美他嗪联合治疗对冠心病患者心功能、炎症因子和内皮功能的影响[J].海南医学院学报,2016,22(14):1489~1492.
[3] 冒益芳.曲美他嗪联合阿托伐他汀治疗冠心病的疗效及对患者血脂和血液流变学的影响[J].中国基层医药,2014,21(2):195~197.
[4] 刘永东,高亢.阿托伐他汀联合曲美他嗪治疗冠心病的临床疗效[J].中国循证心血管医学杂志,2016,8(3):370~371,376.
[5] Girinsky T,M'Kacher R,Lessard N,et al.Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: Results and risk factor analysis[J].International Journal of Radiation Oncology Biology Physics,2014,89(1):59~66.
[6] Kirisli HA,Schaap M,et al.Standardized evaluation framework for evaluating coronary artery stenosis detection, stenosis quantification and lumen segmentation algorithms in computed tomography angiography[J].Medical Image Analysis,2014,17(8):859~876. |
|
|
|
2017, Vol. 23 
